Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands. (Q54128073)

25 May 2018

title

Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands. (English)

1 reference

25 May 2018

0 references

Kuner P

1

1 reference

25 May 2018

Bohrmann B

2

1 reference

25 May 2018

Tjernberg LO

3

1 reference

25 May 2018

Näslund J

4

1 reference

25 May 2018

Huber G

5

1 reference

25 May 2018

Celenk S

6

1 reference

25 May 2018

Grüninger-Leitch F

7

1 reference

25 May 2018

Richards JG

8

1 reference

25 May 2018

Jakob-Roetne R

9

1 reference

25 May 2018

Kemp JA

10

1 reference

25 May 2018

Nordstedt C

11

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

25 May 2018

Journal of Biological Chemistry

published in

1 reference

25 May 2018

volume

275

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

1673-1678

1 reference

25 May 2018

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

pH-dependent structural transitions of Alzheimer amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

A molecular model of Alzheimer amyloid beta-peptide fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Controlling amyloid beta-peptide fibril formation with protease-stable ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Structural basis for the binding of proline-rich peptides to SH3 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

A beta deposition inhibitor screen using synthetic amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Purification and structural studies of a major scrapie prion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Chrysamine-G, a lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

The mechanism of action of cyclosporin A and FK506

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

An ApoE-Abeta inhibition complex in Abeta fibril extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

A strategy for designing inhibitors of beta-amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.3.1673

21 January 2018

Identifiers

DOI

10.1074/JBC.275.3.1673

1 reference

25 May 2018

PubMed ID

10636861

1 reference

25 May 2018